Capstone Investment Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,439
Closed -$2.57M 1894
2025
Q4
$2.57M Buy
15,439
+5,428
+54% +$908K 0.01% 533
2025
Q3
$1.96M Buy
+10,011
New +$1.65M ﹤0.01% 768
2024
Q2
Sell
-62,400
Closed -$4.63M 2537
2024
Q1
$4.63M Buy
+62,400
New +$4.62M 0.02% 470

Other funds holding ALAB

Capstone Investment Advisors's ALAB Position: Q1 2026 in Review

Capstone Investment Advisors sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 15,439 shares — an estimated $2.57M sold.

Capstone Investment Advisors first reported a position in ALAB in Q1 2024 and held it in 3 quarters. The position peaked at $4.63M in Q1 2024. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Capstone Investment Advisors reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 15,439 Astera Labs shares in Q1 2026, an estimated $2.57M.
  • Capstone Investment Advisors first reported a position in Astera Labs in Q1 2024 and held it in 3 quarters.
  • Capstone Investment Advisors's Astera Labs position peaked at $4.63M in Q1 2024.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.